Tagged: Prodrugs

Adam Renslo, PhD


My research group is engaged at the interface of chemistry and biology. As medicinal chemists, we design and synthesize small molecules that modulate disease pathology at the level of the enzyme, cell, and whole animal, with current projects in cancer, infectious disease, and neurodegeneration. As...

Daniel Santi, MD, PhD


Since my retirement in 2000, I became CEO of Kosan Biosciences. I returned to UCSF in 2007 where I served as interim Director of the UCSF CTSI and then Director of Translational Research at QB3.

Paul Ortiz de Montellano, PhD


My laboratory investigates the mechanisms of heme proteins, the roles they play, and approaches for their inhibition in therapeutic situations of enzymes in both humans and bacteria that have heme groups.